These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4364736)

  • 1. Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets.
    Zbar B; Ribi E; Meyer T; Azuma I; Rapp HJ
    J Natl Cancer Inst; 1974 May; 52(5):1571-7. PubMed ID: 4364736
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapy of guinea pig cancer with BCG.
    Zbar B; Rapp HJ
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1532-40. PubMed ID: 4371315
    [No Abstract]   [Full Text] [Related]  

  • 4. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG).
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():71-85. PubMed ID: 4362524
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapy of cancer: regression of tumors after intralesional injection of living Mycobacterium bovis.
    Zbar B; Tanaka T
    Science; 1971 Apr; 172(3980):271-3. PubMed ID: 4323415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterial cell wall components in tumor suppression and regression.
    Ribi EE; Meyer TJ; Azuma I; Zbar B
    Natl Cancer Inst Monogr; 1973 Dec; 39():115-9. PubMed ID: 4595311
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor suppression by cell walls of mycobacterium bovis attached to oil droplets.
    Zbar B; Rapp HJ; Ribi EE
    J Natl Cancer Inst; 1972 Mar; 48(3):831-5. PubMed ID: 4333775
    [No Abstract]   [Full Text] [Related]  

  • 8. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1973 Dec; 51(6):1897-908. PubMed ID: 4358147
    [No Abstract]   [Full Text] [Related]  

  • 9. BCG and cancer (first of two parts).
    Bast RC; Zbar B; Borsos T; Rapp HJ
    N Engl J Med; 1974 Jun; 290(25):1413-20. PubMed ID: 4364286
    [No Abstract]   [Full Text] [Related]  

  • 10. Ultrastructural studies of histiocyte-tumor cell interactions during tumor regression after intralesional injection of Mycobacterium bovis.
    Snodgrass MJ; Hanna MG
    Cancer Res; 1973 Apr; 33(4):701-16. PubMed ID: 4348772
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunotherapy of cancer: regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis.
    Zbar B; Bernstein ID; Bartlett GL; Hanna MG; Rapp HJ
    J Natl Cancer Inst; 1972 Jul; 49(1):119-30. PubMed ID: 4338767
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy with nonviable microbial components.
    Ribi E; Milner KC; Granger DL; Kelly MT; Yamamoto K; Brehmer W; Parker R; Smith RF; Strain SM
    Ann N Y Acad Sci; 1976; 277(00):228-38. PubMed ID: 187099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvants for a tumor-specific vaccine: Bordetella pertussis or mycobacterial cell walls attached to oil droplets.
    Bartlett GL; Zbar B
    J Natl Cancer Inst; 1973 May; 50(5):1385-90. PubMed ID: 4351399
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotherapy of guinea pigs with dermal and visceral tumor implants: comparison of living and nonliving BCG.
    Yarkoni E; Peters L; Rapp HJ; Hanna MG; Hunter JT
    Infect Immun; 1979 May; 24(2):565-66. PubMed ID: 378859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumor chemoimmunotherapy with mitomycin C and components from mycobacteria in regression of line 10 tumors in guinea pigs.
    McLaughlin CA; Cantrell JL; Ribi E; Goldberg EP
    Cancer Res; 1978 May; 38(5):1311-6. PubMed ID: 205361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant activity of mycobacterial fractions. I. Purification and in vivo adjuvant activity of cell wall skeletons of Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8.
    Azuma I; Kanetsuna F; Taniyama T; Yamamura Y; Hori M
    Biken J; 1975 Mar; 18(1):1-13. PubMed ID: 807194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of cell-wall skeleton of Propionibacterium acnes C7 in mice and guinea pigs.
    Azuma I; Yamawaki M; Yoshimoto T; Saiki I; Uemiya M; Tanio Y; Tokuzen R; Yasumoto K; Yamamura Y
    Gan; 1979 Dec; 70(6):737-48. PubMed ID: 395008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologically active components from mycobacterial cell walls. IV. Protection of mice against aerosol infection with virulent mycobacterium tuberculosis.
    Ribi E; Meyer TJ; Azuma I; Parker R; Brehmer W
    Cell Immunol; 1975 Mar; 16(1):1-10. PubMed ID: 803876
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy of cancer with cell wall skeleton of Myocabacterium bovis-Bacillus Calmette-Guérin: experimental and clinical results.
    Yamamura Y; Azuma I; Taniyama T; Sugimura K; Hirao F; Tokuzen R; Okabe M; Nakahara W; Yasumoto K; Ohta M
    Ann N Y Acad Sci; 1976; 277(00):209-27. PubMed ID: 826205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression and regression of a transplanted tumor in the guinea pig colon mediated by Mycobacterium bovis, strain BCG.
    Harmel RP; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1975 Feb; 54(2):515-7. PubMed ID: 234537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.